本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pacira Pharmaceuticals

24.41
-0.2700-1.09%
成交量:2.80萬
成交額:68.65萬
市值:9.73億
市盈率:69.39
高:24.83
開:24.63
低:24.34
收:24.68
52周最高:27.66
52周最低:18.80
股本:3,986.19萬
流通股本:3,636.93萬
量比:0.56
換手率:0.08%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
淨資產收益率:2.05%
總資產收益率:1.48%
市淨率:1.45
市盈率(LYR):154.66

資料載入中...

2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

重要事件披露

8-K - Current report
2023/04/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/03

重要事件披露

8-K - Current report
2023/03/22

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals